Basilea Pharmaceutica AG

BPMUF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$15,802$56,856$20,737-$21,389
Dep. & Amort.$1,334$535$1,197$1,724
Deferred Tax$0$0$0$2,635
Stock-Based Comp.$2,829$2,564$2,502$1,249
Change in WC$2,110$8,221$1,152$9,179
Other Non-Cash$981-$11,733-$7,668-$1,016
Operating Cash Flow$23,056$56,443$17,920-$7,619
Investing Activities
PP&E Inv.-$321-$1,243-$467-$645
Net Acquisitions$0$781$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$93-$810$728$0
Investing Cash Flow-$414-$1,272$261-$645
Financing Activities
Debt Repay.$0-$15,603-$15,603$0
Stock Issued$0-$2,187$4,626$1,047
Stock Repurch.$0$0$0-$384
Dividends Paid$0$0$0$0
Other Fin. Act.-$14,470$13,142$2,461-$40,222
Financing Cash Flow-$14,470-$22-$13,142-$40,222
Forex Effect-$11-$59$109-$139
Net Chg. in Cash$132,721$55,090$56,981-$78,459
Supplemental Information
Beg. Cash$0$69,470$12,489$90,948
End Cash$132,721$124,560$69,470$12,489
Free Cash Flow$22,735$55,118$17,453-$8,264
Basilea Pharmaceutica AG (BPMUF) Financial Statements & Key Stats | AlphaPilot